AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021
Feb 26, 2021
32782_dirs_2021-02-26_8cac9ce4-4671-49b1-ba23-c0895f79c1fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-02-25
Reporting Person: Kinney Gene G. (President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-25 | Stock Option (Right to Buy) | $22.60 | A | 250000 | Acquired | 2031-02-25 | Ordinary Shares (250000) | Direct |
| 2021-02-25 | Stock Option (Right to Buy) | $12.15 | A | 50000 | Acquired | 2030-02-25 | Ordinary Shares (50000) | Direct |
Footnotes
F1: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
F2: On February 25, 2020, the reporting person was granted an option to purchase 50,000 ordinary shares. The shares subject to the option vested in full based on the achievement of certain performance criteria.